Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
3/23/2026
Dizal Reports Positive Phase III WU-KONG28 Results for Sunvozertinib i...
3/23/2026
Sun-Novo Licenses STC007 to Salubris Pharma in Greater China Deal Wort...
3/23/2026
Everest Medicines Acquires Greater China Rights to Etripamil Nasal Spr...
3/23/2026
Mabgalaxy Raises Near CNY 100M Angel Round to Advance AI-Driven Antibo...
3/20/2026
AstraZeneca Expands UK–China Strategy With Cell Therapy R&D Hub and M...
3/20/2026
Alebund Licenses First-in-Class Kidney Drug AP306 to R1 Therapeutics i...
3/20/2026
ELCC 2026: BioKin–Henlius Combo Shows First-Line Promise in ES-SCLC
3/20/2026
NovaBridge Secures FDA Alignment on Accelerated Pathway for Givastomig...
3/20/2026
Excalipoint Launches With $68.7M Seed to Advance Next-Generation TCE P...
3/20/2026
Kintor Reports Positive Phase III Results for First-in-Class Hair Loss...
3/20/2026
Cloudbreak Pharma Withdraws China IND for CBT-009, Refocuses Ophthalmo...
3/20/2026
Recent Executive Moves
3/17/2026
China Issues New Policy to Strengthen Primary Healthcare Through Medic...
3/17/2026
New NHSA Report Highlights Expanding Coverage and Reforms in China’s ...
3/17/2026
Fosun Pharma Subsidiary Secures China Approval for Novel Hair-Loss The...
3/17/2026
Essight Wins FDA Clearance for First Clinical Trial of RAS G12V Bispec...
3/17/2026
CDE Seeks Comment on Draft Guideline for Advancing Oncology Drugs to F...
3/17/2026
CDE Issues Guideline on Dose Extrapolation for Neonates and Young Infa...
3/17/2026
Merck KGaA Aims to Deepen Partnerships in China's Pharmaceutical Innov...
3/17/2026
PegBio Partners With Tenry Pharma to Commercialize Paidakang in Mainla...
3/17/2026
Gyre Thera Liver Fibrosis Drug Receives Priority Review in China
3/17/2026
Innorna Wins FDA Clearance to Test mRNA Therapy for Refractory Gout in...
3/17/2026
NHSA: China Medical Insurance Revenue Growth Outpaces Spending in 2025
3/17/2026
China to Grant Market and Data Exclusivity for Innovative Drugs for th...
3/17/2026
US Reshoring Push Clouds Long-Term Outlook for China's Contract Drugma...
3/16/2026
CirCode Wins FDA Clearance to Test Circular RNA Therapy
3/16/2026
3SBio Wins U.S. FDA Clearance to Advance Metabolic Disease Antibody SS...
3/16/2026
KangaBio Advances Oncology Pipeline with FDA IND Clearance
3/13/2026
UniXell Secures FDA Clearance to Begin Clinical Testing of iPSC-Derive...
3/13/2026
Jeyou Pharma Raises About CNY 2B in Series A to Advance Clinical Pipel...
Page:
9
/
831
Total number of articles:
24902
:
[First]
[<<]
[7]
[8]
[9]
[10]
[11]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit